Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient

Journal of Human Hypertension

Volumn 13, Issue 1, 1999, Pages 61-67

  Holzgreve, Heinrich ^a   Compagnone, D ^b   Zilles, P ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Knoll AG   (Germany)

Author keywords

Efficacy; Elderly; Essential hypertension; Tolerability; Verapamil trandolapril combination therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT; OCADRIK; TRANDOLAPRIL PLUS VERAPAMIL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRAIN ISCHEMIA; CLINICAL TRIAL; COUGHING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HEART PALPITATION; HOT FLUSH; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RASH; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VERTIGO;

EID: 0032893837     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000728     Document Type: Article

References (30)

1. Thijs L et al. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992; 10: 1103-1109.
2. Holzgreve H, Middecke M. Treatment of hypertension in the elderly. Drugs 1993; 46 (Suppl 2): 24-31.
3. Hansson L. Future goals for the treatment of hypertension in the elderly with reference to STOP-hypertension. SHEP and the MRC trial in older adults. Am J Hypertens 1993; 6: 40S-43S.
4. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organisation/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-918.
5. Lithell H. Insulin resistance and cardiovascular drugs. Clin Exp Hypertens [A] 1992; 14: 151-162.
6. Bakris GL. Hypertension in diabetic patients. Am J Hypertens 1993; 6: 140S-147S.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-301.
8. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-691.
9. Pfeffer MA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327 (10): 669-677.
10. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. ACE inhibition, atherosclerosis and myocardial infarction - the AIRE Study in practice. Eur Heart J 1994; 15 (Suppl B): 20-25.
11. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991; 67: 1295-1297.
12. Wiseman LR, McTavish D. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs 1994; 48(1): 71-90.
13. Scholze J, Zilles P, Compagnone D. Verapamil SR and trandolapril combination therapy in hypertension - a clinical trial of factorial design. Br J Clin Pharmacol 1998; 45: (in press).
14. Lenfant B et al. Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers. J Cardiovasc Pharmacol 1994; 23 (Suppl 4): S38-S43.
15. Schöbel D. Simultaneous determination of verapamil and N-desmethlyverapamil in plasma by high performance liquid chromatography with spectrofluoroscence detection. Knoll AG, internal report MPF/HB 9311.
16. The Veratran Study Group. Effects of verapamil SR, trandolapril and their fixed combination on 24 hour blood pressure. Am J Hypertens 1997; 10: 492-499.
17. De Quattro V, Lee d, Messerlli F. Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: A 4 × 4 trial design. Clin and Exper Hypertens 1997; 19(3): 373-387.
18. Viskoper RJ, Compagnone D, Dies R, Zilles P. Verapamil and trandolapril alone and in fixed combination in moderate essential hypertension: A multicenter, double masked study. Curr Ther Res 1997; 58: 331-342.
19. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people for clinical research: A descriptive study of published papers. BMJ 1997; 315: 1059.
20. Avorn J, Gurwitz JH. Principles of pharmacology. In: Cassel CK, Cohen G, Larsen E, eds. Geriatric medicine. 3rd edn. Springer: New York, 1997.
21. Gurwitz JH et al. Thiazide diuretics and initiation of anti-gout therapy. J Clin Epidemiol 1997; 50: 953-959.
22. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981; II: 539-543.
23. Backhouse CI, Orofiamma B, Pauly NC, for the Investigator Study Group. Long-term therapy with trandolapril, a new non-sulphydryl ACE inhibitor in hypertension: a multicenter international trial. J Cardiovasc Pharmacol 1994; 23 (Suppl 4): S86-S90.
24. Brogden RN, Todd PA, Sorkin EM. Captopril. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs 1988; 36: 540-600.
25. Todd PA, Goa KL. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension. Drugs 1992; 43: 346-381.
26. Frishman WH et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med 1994; 154: 1461-1468.
27. Prisant LM et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J 1995; 130: 359-366.
28. Fioretto P et al. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992; 5: 837-846.
29. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992; 41: 912-919.
30. Fischer Hansen J et al. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Am J Cardiol 1997; 79: 738-741.